These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 16039041

  • 1. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF.
    Cancer Lett; 2006 Jul 08; 238(1):42-52. PubMed ID: 16039041
    [Abstract] [Full Text] [Related]

  • 2. Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer.
    Jin MC, Qian ZJ, Megwalu UC.
    Anticancer Res; 2022 Mar 08; 42(3):1359-1365. PubMed ID: 35220228
    [Abstract] [Full Text] [Related]

  • 3. Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy.
    Rose J, Wertheim BC, Guerrero MA.
    Am J Surg; 2012 Dec 08; 204(6):881-6; discussion 886-7. PubMed ID: 23026382
    [Abstract] [Full Text] [Related]

  • 4. Radiotherapy for oral cancer as a risk factor for second primary cancers.
    Hashibe M, Ritz B, Le AD, Li G, Sankaranarayanan R, Zhang ZF.
    Cancer Lett; 2005 Apr 08; 220(2):185-95. PubMed ID: 15766594
    [Abstract] [Full Text] [Related]

  • 5. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB.
    J Natl Cancer Inst; 2007 Nov 07; 99(21):1634-43. PubMed ID: 17971527
    [Abstract] [Full Text] [Related]

  • 6. Cancer incidence after localized therapy for prostate cancer.
    Moon K, Stukenborg GJ, Keim J, Theodorescu D.
    Cancer; 2006 Sep 01; 107(5):991-8. PubMed ID: 16878323
    [Abstract] [Full Text] [Related]

  • 7. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
    Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD.
    J Clin Endocrinol Metab; 2008 Feb 01; 93(2):504-15. PubMed ID: 18029468
    [Abstract] [Full Text] [Related]

  • 8. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.
    Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E.
    Lancet Oncol; 2011 Apr 01; 12(4):353-60. PubMed ID: 21454129
    [Abstract] [Full Text] [Related]

  • 9. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
    Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I.
    Cancer; 2011 Oct 01; 117(19):4439-46. PubMed ID: 21432843
    [Abstract] [Full Text] [Related]

  • 10. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A, Wong J, Kleinerman R, Kim C, Morton L, Bekelman JE.
    Int J Radiat Oncol Biol Phys; 2015 Feb 01; 91(2):295-302. PubMed ID: 25636756
    [Abstract] [Full Text] [Related]

  • 11. Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer.
    Polednik KM, Simpson MC, Adjei Boakye E, Mohammed KA, J Dombrowski J, Varvares MA, Osazuwa-Peters N.
    Laryngoscope; 2019 Apr 01; 129(4):1014-1020. PubMed ID: 30208210
    [Abstract] [Full Text] [Related]

  • 12. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
    Brown AP, Neeley ES, Werner T, Soisson AP, Burt RW, Gaffney DK.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):127-35. PubMed ID: 19910129
    [Abstract] [Full Text] [Related]

  • 13. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
    Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, Stiller CA, Stevens MC, Hawkins MM.
    Int J Cancer; 2009 Nov 15; 125(10):2400-5. PubMed ID: 19610069
    [Abstract] [Full Text] [Related]

  • 14. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):669-73. PubMed ID: 16887293
    [Abstract] [Full Text] [Related]

  • 15. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ.
    J Natl Cancer Inst; 2016 Feb 01; 108(2):. PubMed ID: 26538627
    [Abstract] [Full Text] [Related]

  • 16. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
    Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP.
    Thyroid; 2009 May 01; 19(5):451-7. PubMed ID: 19281429
    [Abstract] [Full Text] [Related]

  • 17. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.
    Farioli A, Violante FS, Mattioli S, Curti S, Kriebel D.
    Cancer Causes Control; 2013 Aug 01; 24(8):1535-45. PubMed ID: 23702885
    [Abstract] [Full Text] [Related]

  • 18. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
    Huo D, Hetzel JT, Roy H, Rubin DT.
    Cancer Epidemiol Biomarkers Prev; 2009 Jul 01; 18(7):1979-85. PubMed ID: 19531678
    [Abstract] [Full Text] [Related]

  • 19. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.
    Bhattacharyya N, Chien W.
    Ann Otol Rhinol Laryngol; 2006 Aug 01; 115(8):607-10. PubMed ID: 16944659
    [Abstract] [Full Text] [Related]

  • 20. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.
    Farioli A, Ottone M, Morganti AG, Compagnone G, Romani F, Cammelli S, Mattioli S, Violante FS.
    Cancer Med; 2016 May 01; 5(5):950-9. PubMed ID: 26860323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.